Company / Income Tax per Share
Ligand Pharmaceuticals, Inc. Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$1.81
FY2025
5-year range
-$0.26 / $2.46
FY2021-FY2025
Trend
+384.1%
vs FY2024
Sector context
#11 of 201
Health Care
What the data says
Income Tax per Share changed +384% YoY in FY2025, a notable deviation from the 9-year average annual change of +221%.
Based on SEC 10-K filings.
1.81 in FY2025 with a 3-year CAGR of -9.8%. Top quartile in the Health Care sector.
Increased from $0.58 to $1.81 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -9.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 201This company $1.81 Sector average $1.35
▼
+34.0% above sector average
Key checks
Key Insights
- In FY2025, income tax per share increased 384.1% year-over-year.
- Ranks #11 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2019.
- Lowest income tax per share in the period was in FY2020.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.81 | +384.1% |
| FY2024 | $0.37 | -35.7% |
| FY2023 | $0.58 | -76.4% |
| FY2022 | $2.46 | +1053.2% |
| FY2021 | -$0.26 | +18.2% |
| FY2020 | -$0.32 | -103.9% |
| FY2019 | $8.06 | +467.9% |
| FY2018 | $1.42 | -33.6% |
| FY2017 | $2.14 | +312.7% |
| FY2016 | $0.52 | +105.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026